First patient has new cutting-edge therapy for cancer patients
Oxford University Hospitals is now a highly specialised NHS centre offering CAR-T therapies to people with cancer, after NHS England expanded access to the potentially life-saving treatment. The cutting-edge therapy, which use a patient’s own immune cells to create a tailored treatment, has been made available through the Cancer Drugs Fund (CDF) for people with certain forms of blood cancer.
It is a highly complex and potentially risky treatment but it has been shown in trials to cure some patients, even those with quite advanced cancers where other available treatments have failed. Blood cancer patients, especially when they relapse, have a poor prognosis, and generally do not survive very long. This new service is expected to deliver this life-saving treatment to at least 20-30 patients each year, giving hope to more patients with blood cancer than ever before. Four patients have now been cared for with this new treatment at OUH.
Published on the 24th of october 2023. Read the entire news report here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (20 mai 2024). First patient has new cutting-edge therapy for cancer patients. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/11ory





